Select your location
Kaitlin
April 15, 2020
April 15, 2020 How will coronavirus-related supply chain disruptions drive companies to rethink manufacturing location strategies? Will North American companies with Asian operations seek to relocate back home? How fast should companies act? How can manufacturers manage their workforce needs and best serve customers today? “In terms of how supply chains have evolved over time, thirty, forty years of globalization have resulted in the concentration of supply chains in some industries that haven’t been apparent to anybody until the epidemic” explained Dennis Meseroll, Tractus Executive Director and Co-Founder in this week’s webinar with Michelle Comerford of Biggins Lacy Shapiro & Company. “We’ve come to see that for some types of products and services, there’s way too many eggs in too few baskets around the world. For example, 99% of the world’s active pharmaceutical ingredient in aspirin is produced in China.”
Recent Insights
Vietnam Investment Law 2026: Key changes for foreign investors
Asia-Pacific Site Selection in 2026: 5 Predictions That Will Shape Investment Decisions
Tractus M&A Partners advises Rohto Pharmaceutical on acquisition of Thailand wellness brand THANN
New Investment Law enables company formation before project approval and removes 38 conditional business lines. On 11 December 2025, ...
[Bangkok, Thailand, 8 January 2026] – Tractus is pleased to announce that its corporate finance arm – Tractus M&A Partners ...
Stay updated and make informed decisions.
Global market trends | Economic performance | Financial updates | Trade analysis